Gynecologic Cancer,Other Cancers Mirvetuximab Soravtansine PK Analysis in FRα-Positive Cancer Patients May 08, 2023
Gynecologic Cancer,Other Cancers Atezolizumab and Chemotherapy for Advanced Ovarian Cancer May 08, 2023
Gynecologic Cancer,Other Cancers Defining Benefit of Rucaparib Maintenance in Newly Diagnosed Ovarian Cancer: ATHENA-MONO Phase III Study May 08, 2023
Gynecologic Cancer,Other Cancers Maintenance Selinexor vs Placebo in Endometrial Cancer: SIENDO Study May 08, 2023
Gynecologic Cancer,Other Cancers Rucaparib Maintenance Benefit in High-Grade Ovarian Carcinoma: ARIEL3 Exceptional Responders May 08, 2023
Gynecologic Cancer,Other Cancers Lenvatinib + Pembrolizumab in Advanced Endometrial Cancer: Updated KEYNOTE-775 Results May 08, 2023
Gynecologic Cancer,Ovarian Cancer Efficacy of Chemotherapy in BRCA1/2-Mutated Recurrent Epithelial Ovarian Cancer: SOLO2 Phase 3 Trial Apr 17, 2023
Gynecologic Cancer,Ovarian Cancer Patient Evaluation of Atezolizumab Added to Standard Treatment of PSROC Mar 28, 2023